The last decade has seen a dramatic improvement in the life expectancy (LE) of people with HIV (PWH) in settings with access to effective antiretroviral therapy. As a result, there has been a change in the spectrum of clinical events that are now commonly seen in PWH, with a reduction in the incidence of most AIDS events but an increase in the incidence of co-morbidities usually seen in an ageing population. The jury is still out on whether successfully treated PWH experience an increased risk of these age-related co-morbidities compared to their HIV-negative counterparts. This presentation will summarise the latest data on LE and the co-morbidities that are seen in PWH and will consider whether LE has now ‘normalised’ in comparison with that of the HIV-negative population, drawing attention to the possible methodological biases that may be present when undertaking such a comparison. The presentation will also investigate whether there are important subsets of PWH in whom LE remains substantially shorter than desired, and where interventions to further improve LE may be required.